MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial

OBJECTIVES: To investigate changes in the Apparent Diffusion Coefficient (ADC) using diffusion-weighted imaging (DWI) in men on active surveillance for prostate cancer taking dutasteride 0.5 mg or placebo. METHODS: We analysed 37 men, randomised to 6 months of daily dutasteride (n = 18) or placebo (...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur Radiol
Glavni autori: Giganti, Francesco, Moore, Caroline M., Robertson, Nicola L., McCartan, Neil, Jameson, Charles, Bott, Simon R. J., Winkler, Mathias, Gambarota, Giulio, Whitcher, Brandon, Castro, Ramiro, Emberton, Mark, Allen, Clare, Kirkham, Alex
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2017
Teme:
Urogenital
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635085/
https://ncbi.nlm.nih.gov/pubmed/28523355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-017-4858-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items